VL
Vertical Longevity Pharmaceuticals, Inc.
StreetZero Signal 66
About Vertical Longevity Pharmaceuticals, Inc.
Vertical Longevity Pharmaceuticals, Inc. is a biotechnology company developing a vaccine targeting atherosclerosis and systemic aging. The company focuses on an immunotherapy for cardiovascular and aging-related disease. It is based in Irvine, California and was founded in 2024.
LATEST FUNDINGPrivate Placement
$110K
Announced 2026-09-28
TOTAL RAISED$110,000
IN THE NEWS
- ๐ Vertical Longevity Pharma โ Netcapital
- ๐ Vertical Pharmaceuticals - 2026 Company Profile, Team & Competitors - Tracxn
- ๐ Klothea Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- ๐ Calico Labs - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- ๐ Vertical - Wikipedia
EMPLOYEESโ
FOUNDED2024
HQIrvine, CA, United States
Industry
Biotechnology
Tags
BiotechnologyVaccineImmunotherapyAging
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Raised $110,000 via private placement in Irvine, CA.
- Developing vaccine for atherosclerosis and systemic aging.
- Campaign on Netcapital surpassed $10,000 milestone for cardiovascular immunotherapy.
- Proceeds allocated to R&D labor, subcontracts with Wake Forest CTSI, and manufacturing co-development.
Ask StreetZero about Vertical Longevity Pharmaceuticals, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account